Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eve vs Marek Health

Eve
Graded #210

Lower grade

vs+0.9000000000000057
Marek Health
Graded #181

Higher grade

The verdict

Marek Health takes it — 66.9/100 to 66/100, but only just.

Marek Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Marek Health is a performance-focused telehealth platform pairing US clients with partnered physicians and health coaches for GLP-1 weight-loss therapy (semaglutide and tirzepatide), comprehensive lab… Eve is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEve +9
54
45
Dose & formulationEve +48
88
40
Clinical oversightMarek Health +14
79
93
Labs & monitoringMarek Health +45
52
97
FulfillmentMarek Health +17
67
84
Contract termsMarek Health +14
41
55
Eve · left barMarek Health · right bar

The numbers

MetricEveMarek Health
WeighScore66/10066.9/100
GradeCC
Scorecard rank#210#181
Semaglutide$195/mo (compounded)Not disclosed
Tirzepatide$195/mo (compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Eve

Graded #210 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated
Marek Health

Graded #181 · C

Strengths

  • Lab panels are core: initial comprehensive labs + 6–12 week follow-up + ongoing every 6 months — rare among GLP-1 providers
  • Dedicated Health Coach paired with each client alongside partnered licensed physician as standard Proactive Care Team
  • All 50 US states served; 100% telehealth with routine physician check-ins every 6 months built into the program
  • Human optimization framing attracts pragmatic patients; partnered physicians selected for data-driven, high-leverage mindset
  • No set subscription plan — custom protocol built around client health goals with option to cancel anytime

Where it loses points

  • Pricing fully gated — no published rates; intake assessment required before quotes, limiting upfront comparison shopping
  • Annual in-person physical required from own PCP or urgent care (every 12 months) — not provided by Marek Health
  • No LegitScript certification found; platform explicitly disclaims being a healthcare clinic, which reduces regulatory trust signals
  • Weight loss is one of many services alongside TRT, hair, brain focus, sexual health — not a dedicated GLP-1 platform
  • Compounded vs. brand medication details not disclosed publicly — medication type determined post-intake with partnered physician

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard